Evidence map›Paper›PMID 31694223›Full record

ReviewJournal of clinical medicine2019

Resistant/Refractory Hypertension and Sleep Apnoea: Current Knowledge and Future Challenges.

Grace Oscullo, Gerard Torres, Francisco Campos-Rodriguez, Tomás Posadas, Angela Reina-González, Esther Sapiña-Beltrán, Ferrán Barbé, Miguel Angel Martinez-Garcia

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Sleep Quality in Patients with Heart Failure in the Spanish Population: A Cross-Sectional Study.International journal of environmental research and public health · 2020
    Article
  16. Article
  17. Article
  18. Obstructive sleep apnea, hypertension, resistant hypertension and cardiovascular disease.Sleep medicine and disorders : international journal · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Grace OsculloPneumology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.
Gerard TorresGroup of Translational Research in Respiratory Medicine, IRBLleida, Hospital Universitari Arnau de Vilanova and Santa Maria, 25198 Lleida, Spain.ORCID 0000-0002-7717-0978
Francisco Campos-RodriguezRespiratory Department, Hospital Valme, 41014 Seville, Spain.
Tomás PosadasPneumology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.
Angela Reina-GonzálezRespiratory Department, Hospital Valme, 41014 Seville, Spain.
Esther Sapiña-BeltránGroup of Translational Research in Respiratory Medicine, IRBLleida, Hospital Universitari Arnau de Vilanova and Santa Maria, 25198 Lleida, Spain.
Ferrán BarbéGroup of Translational Research in Respiratory Medicine, IRBLleida, Hospital Universitari Arnau de Vilanova and Santa Maria, 25198 Lleida, Spain.
Miguel Angel Martinez-GarciaPneumology Department, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.ORCID 0000-0002-7321-1891

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is one of the most frequent cardiovascular risk factors. The population of hypertensive patients includes some phenotypes whose blood pressure levels are particularly difficult to control, thus putting them at greater cardiovascular risk. This is especially true of so-called resistant hypertension (RH) and refractory hypertension (RfH). Recent findings suggest that the former may be due to an alteration in the renin-angiotensin-aldosterone axis, while the latter seems to be more closely related to sympathetic hyper-activation. Both these pathophysiological mechanisms are also activated in patients with obstructive sleep apnoea (OSA). It is not surprising, therefore, that the prevalence of OSA in RH and RfH patients is very high (as reflected in several studies) and that treatment with continuous positive airway pressure (CPAP) manages to reduce blood pressure levels in a clinically significant way in both these groups of hypertensive patients. It is therefore necessary to incorporate into the multidimensional treatment of patients with RH and RfH (changes in lifestyle, control of obesity and drug treatment) a study of the possible existence of OSA, as this is a potentially treatable disease. There are many questions that remain to be answered, especially regarding the ideal combination of treatment in patients with RH/RfH and OSA (drugs, renal denervation, CPAP treatment) and patients' varying response to CPAP treatment.

Indexed as

Continuous positive airway pressureObstructive sleep apnoeaRefractory hypertensionResistant hypertension

Identifiers

PMID31694223
PMCPMC6912579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.